Search clinical trials for: docetaxel S-1

Total 17997 results

Cancer Institute and Hospital, Chinese Academy...

Completed

A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma

Stomach Neoplasms | Chemotherapy | Neoadjuvant Therapy | Chemoradiotherapy

China
Ruijin Hospital

Recruiting

Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer

Stage IIIC Gastric Cancer

China
Taiho Oncology, Inc.

Completed

Evaluating Patients With Impaired Hepatic Function

Impaired Hepatic Function

United States
National Cancer Center, Korea

Unknown

Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma

Stomach Neoplasms

Korea, Republic of
Sanofi

Completed

Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer (PRODIGY)

Gastric Cancer

Korea, Republic of
Tianjin Medical University Cancer Institute and...

Recruiting

Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric Cancer

Gastric Cancer | Perioperative | Sintilimab

China
Capital Medical University
Duke University; Geneplus-Beijing Co. Ltd.

Completed

Study of S-1 Plus DC-CIK for Patients With Advanced Gastric Cancer

Gastric Cancer

China
Samsung Medical Center

Terminated

Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT

Phase I: To Determine the Maximum Tolerated Dose (MTD) | Phase II: To Assess the Pathologic CR Rate and Feasibility Following Neoadjuvant Chemoradiation Therapy With S1/Oxaliplatin

Korea, Republic of
Yonsei University

Completed

Neoadjuvant Combination Chemotherapy of DCS (Cisplatin + Docetaxel + S-1) and DCF (Docetaxel + Cisplatin + 5-FU) in Patients With Locally Advanced Gastric Adenocarcinoma

Gastric Cancer

Korea, Republic of
The Affiliated Hospital of the Chinese Academy...

Unknown

Study of S-1 as Second Line Treatment on Advanced Pancreatic Cancers (APC-S1)

Pancreatic Cancer

China
Sichuan University

Not yet recruiting

To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

Gastric Cancer
Sun Yat-sen University
Taiho Pharmaceutical Co., Ltd.

Completed

S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients

Gastric Cancer

China
National Taiwan University Hospital
TTY Biopharm

Terminated

Phase I Study of TS-1 With Concurrent Radiotherapy to Treat Pancreatic Cancer (SR-GS)

Metastatic Pancreatic Cancer

Taiwan
Yonsei University

Terminated

A Phase II Trial of Adjuvant Chemotherapy With S-1 Plus Oxaliplatin for Locally Advanced Gastric Cancer

Advanced Gastric Cancer

Korea, Republic of
Zhejiang University

Recruiting

Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1 (TACTIC)

Locally Advanced Gastric Carcinoma

China
Taiho Pharmaceutical Co., Ltd.

Completed

Study of S-1 Plus LV for Untreated Metastatic Colorectal Cancer

Colorectal Cancer

China, Japan
Jing Jin, M.D.
Beijing Hope Run

Recruiting

A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer

Gastric Cancer | Neoadjuvant Therapy

China
Quantum Genomics SA

Completed

Phase I Study in Healthy Male Subjects Comparing QGC001 to Placebo

Essential Hypertension

France
Sixth Affiliated Hospital, Sun Yat-sen University

Unknown

Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma (mSOX)

Gastric Adenocarcinoma

China
Zhejiang Cancer Hospital

Completed

S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer

Esophageal Cancer

China
Adherex Technologies, Inc.
US Oncology Research

Completed

A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabine

Neoplasms

United States
Kansai Hepatobiliary Oncology Group

Completed

A Phase I Study of Adjuvant Chemotherapy With GS in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy

Biliary Tract Cancer

Japan
Azaya Therapeutics, Inc.

Completed

Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies

Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Solid Tumor | Non-Small Cell Lung

United States
Xijing Hospital

Unknown

Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer

Gastrointestinal Cancer

China
Academisch Medisch Centrum - Universiteit van Amsterdam...
Celgene Corporation

Completed

Feasibility Study of Adjuvant Treatment With S-1 and Oxaliplatin in Patients With Resectable Esophageal Cancer (SOX)

Esophageal Cancer

Netherlands
Shiga University
University of Chicago; Shionogi; Tokyo University; Showa University; Fukushima Medical... and other collaborators

Unknown

Phase II Study of S-488410 to Treat Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Japan
Beijing Konruns Pharmaceutical Co., Ltd.

Recruiting

A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer

Esophageal Squamous Cell Carcinoma

China
Korean Breast Cancer Study Group

Unknown

A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast Cancer (STORM)

Metastatic Breast Cancer | Recurrent Breast Cancer

Korea, Republic of
Japan Breast Cancer Research Network

Completed

Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer

Breast Neoplasms

Japan
Merck KGaA, Darmstadt, Germany

Completed

Cetuximab in Combination With S-1 and Cisplatin in Gastric Cancer

Gastric Cancer

Germany
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM

Gastric Cancer | Gastric Cancer Metastatic to Regional Lymph Nodes

China
Taiho Oncology, Inc.
Quintiles, Inc.

Completed

A Safety and Efficacy Study in Patients With Gastric Cancer

Gastric Cancer

United States, Canada
Osaka Medical Center for Cancer and Cardiovascular...

Completed

Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer

Pancreatic Cancer

Japan
Kansai Hepatobiliary Oncology Group

Unknown

A Phase II Trial of Preoperative Chemotherapy for Biliary Tract Cancer (BTC) With Node Metastasis

Biliary Tract Cancer

Japan
Kansai Hepatobiliary Oncology Group

Completed

Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract Cancer

Biliary Tract Cancer

Japan
Cancer Institute and Hospital, Chinese Academy...

Completed

A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer

Esophageal Cancer | Unresectable Malignant Neoplasm | Chemoradiotherapy | Nimotuzumab

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma

Stomach Neoplasms

China
Affiliated Hospital of Qinghai University

Unknown

Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric Cancer

Gastric Cancer

China
The Central Hospital of Lishui City

Not yet recruiting

Exploratory Clinical Study of Penpulimab Combined With SOX in the Perioperative Treatment of Gastric Cancer

Gastric Cancer
Zhejiang Provincial People's Hospital

Withdrawn

SOX-based CRT for Esophageal Cancer.

Esophageal Cancer

China
Shionogi

Completed

Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis
Huazhong University of Science and Technology
CSPC Ouyi Pharmaceutical Co., Ltd.

Recruiting

Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma

Gastric Cancer

China
Grupo Gallego de Investigaciones Oncologicas
Amgen; Trial Form Support S.L.

Unknown

Efficacy and Safety of Panitumumab Combined With Docetaxel and Cisplatin as a First-line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (SPIGA)

Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma

Spain
Taiho Pharmaceutical Co., Ltd.

Completed

Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer

Cervical Cancer

Japan, Korea, Republic of, Taiwan
Jilin Provincial Tumor Hospital

Unknown

Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) in Patients With Advanced Gastric Cancer

Gastric Cancer

China
Taiho Pharmaceutical Co., Ltd.
Yakult Honsha Co., LTD

Completed

Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer (SOLAR)

Gastric Cancer

Japan, Korea, Republic of
Tang-Du Hospital

Unknown

S-1 Combined Cisplatin HIPEC for Palliative Operation Gastric Cancer of Stage IV Limited Peritoneal Metastasis

Stage IV Gastric Cancer

China
Shandong University

Unknown

Neoadjuvant ECS Versus ECF in Local Advanced Breast Cancer

Breast Neoplasms | Neoadjuvant Therapy

China
U.S. Army Medical Research and Development Command
National Institutes of Health (NIH); Mahidol University

Completed

Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate

Diarrhea | Dysentery | Shigella

Thailand
Gyeongsang National University Hospital
Samsung Medical Center; Dong-A University; Chung-Ang University

Terminated

Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer

Metastatic Biliary Tract Cancer | Locally Advanced Biliary Tract Cancer

Korea, Republic of

Search clinical trials for: docetaxel S-1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations